ArticleAntimicrobial agents and chemotherapy2011

Reduction in fluoroquinolone use following introduction of ertapenem into a hospital formulary is associated with improvement in susceptibility of Pseudomonas aeruginosa to group 2 carbapenems: a 10-year study.

Paul P Cook et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.